Selatogrel
- Generic Name
- Selatogrel
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C28H39N6O8P
- CAS Number
- 1159500-34-1
- Unique Ingredient Identifier
- 6DPK7O4PR7
- Background
Selatogrel is under investigation in clinical trial NCT03814200 (A Study to Investigate the Effect of Rifampicin on the Uptake and Breakdown of ACT-246475 in Healthy Subjects).
- Associated Conditions
- -
- Associated Therapies
- -
A Comparative Study of Selatogrel (ACT-246475) Formulations in Healthy Subjects
- First Posted Date
- 2020-09-21
- Last Posted Date
- 2022-11-16
- Lead Sponsor
- Idorsia Pharmaceuticals Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT04557280
- Locations
- 🇺🇸
Altasciences Clinical Kansas, Inc, Overland Park, Kansas, United States
The Effect of Reduced Liver Function on Selatogrel Pharmacokinetics
- First Posted Date
- 2020-05-29
- Last Posted Date
- 2022-11-16
- Lead Sponsor
- Idorsia Pharmaceuticals Ltd.
- Target Recruit Count
- 24
- Registration Number
- NCT04406896
- Locations
- 🇩🇪
CRS Clinical Research Services, Kiel, Germany
A Study to Investigate the Effect of Rifampicin on the Uptake and Breakdown of ACT-246475 in Healthy Subjects
- First Posted Date
- 2019-01-23
- Last Posted Date
- 2022-11-16
- Lead Sponsor
- Idorsia Pharmaceuticals Ltd.
- Target Recruit Count
- 14
- Registration Number
- NCT03814200
- Locations
- 🇳🇱
QPS Netherlands B.V., Groningen, Netherlands
A Study to Evaluate ACT-246475 Fate in Healthy Male Subjects
- First Posted Date
- 2018-07-20
- Last Posted Date
- 2022-11-16
- Lead Sponsor
- Idorsia Pharmaceuticals Ltd.
- Target Recruit Count
- 6
- Registration Number
- NCT03593278
- Locations
- 🇩🇪
Klinikum der Stadt Ludwigshafen am Rhein gGmbH, Ludwigshafen, Germany
🇩🇪Universitäts-Herzzentrum Bad Krozingen, Bad Krozingen, Germany
🇩🇪Universitäts-Herzzentrum Freiburg, Freiburg, Germany
A Study to Investigate the Interaction Between ACT-246475 and Clopidogrel, Prasugrel, and Ticagrelor in Healthy Subjects
- Conditions
- Interventions
- First Posted Date
- 2018-02-13
- Last Posted Date
- 2022-11-16
- Lead Sponsor
- Idorsia Pharmaceuticals Ltd.
- Target Recruit Count
- 77
- Registration Number
- NCT03430661
- Locations
- 🇺🇸
Biotrial Inc, Newark, New Jersey, United States
A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease
- First Posted Date
- 2017-12-28
- Last Posted Date
- 2022-11-17
- Lead Sponsor
- Idorsia Pharmaceuticals Ltd.
- Target Recruit Count
- 346
- Registration Number
- NCT03384966
- Locations
- 🇺🇸
University of Florida (UF) Jacksonville, Jacksonville, Florida, United States
🇺🇸Florida Hospital Tampa - Pepin Heart Institute, Tampa, Florida, United States
🇺🇸NorthShore University, Chicago, Illinois, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.